Pulmonary surfactant is a mixture of lipids and proteins which is secreted into the alveolar space by epithelial type II cells. The main function of surfactant is to lower the surface tension at the air/liquid interface within the alveoli of the lung.
This report contains market size and forecasts of Pulmonary Surfactant in global, including the following market information:
Global Pulmonary Surfactant Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Pulmonary Surfactant Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Pulmonary Surfactant companies in 2021 (%)
The global Pulmonary Surfactant market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Synthetic Pulmonary Surfactants Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pulmonary Surfactant include Boehringer Ingelheim, AbbVie, Lyomark Pharma, Tekzima (Noargen), ONY Biotech, Abbott, Aviva Systems Biology, LSBio and Biomatik, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pulmonary Surfactant manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pulmonary Surfactant Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Pulmonary Surfactant Market Segment Percentages, by Type, 2021 (%)
Synthetic Pulmonary Surfactants
Animal Derived Surfactants
Global Pulmonary Surfactant Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Pulmonary Surfactant Market Segment Percentages, by Application, 2021 (%)
Hospital
laboratory
Others
Global Pulmonary Surfactant Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Pulmonary Surfactant Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pulmonary Surfactant revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Pulmonary Surfactant revenues share in global market, 2021 (%)
Key companies Pulmonary Surfactant sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Pulmonary Surfactant sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Boehringer Ingelheim
AbbVie
Lyomark Pharma
Tekzima (Noargen)
ONY Biotech
Abbott
Aviva Systems Biology
LSBio
Biomatik
Biorbyt
Reddot Biotech
XpressBio
Creative Diagnostics
Nanjing Norris Pharm Technology
Windtree Therapeutics